PLN 8.05
(0.25%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 346 Thousand PLN | 20.14% |
2022 | 288 Thousand PLN | 5.88% |
2021 | 272 Thousand PLN | 15.25% |
2020 | 236 Thousand PLN | -53.66% |
2019 | 509.3 Thousand PLN | 240.87% |
2018 | 149.41 Thousand PLN | 17.65% |
2017 | 126.99 Thousand PLN | -42.11% |
2016 | 219.39 Thousand PLN | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | -2.83 Million PLN | 0.0% |
2024 Q1 | -2.84 Million PLN | 0.0% |
2023 Q3 | -3000.00 PLN | -100.86% |
2023 Q4 | 346 Thousand PLN | 11633.33% |
2023 FY | 346 Thousand PLN | 20.14% |
2023 Q1 | 348 Thousand PLN | 20.83% |
2023 Q2 | 348 Thousand PLN | 0.0% |
2022 Q3 | 320 Thousand PLN | 2.89% |
2022 Q2 | 311 Thousand PLN | -9.33% |
2022 Q4 | 288 Thousand PLN | -10.0% |
2022 Q1 | 343 Thousand PLN | 26.1% |
2022 FY | 288 Thousand PLN | 5.88% |
2021 FY | 272 Thousand PLN | 15.25% |
2021 Q3 | 180 Thousand PLN | -9.09% |
2021 Q4 | 272 Thousand PLN | 51.11% |
2021 Q1 | 218 Thousand PLN | -7.63% |
2021 Q2 | 198 Thousand PLN | -9.17% |
2020 Q4 | 236 Thousand PLN | -38.48% |
2020 FY | 236 Thousand PLN | -53.66% |
2020 Q3 | 383.6 Thousand PLN | -25.69% |
2020 Q2 | 516.18 Thousand PLN | 0.0% |
2020 Q1 | - PLN | -100.0% |
2019 Q3 | 505.83 Thousand PLN | -32.77% |
2019 Q2 | 752.35 Thousand PLN | 399.5% |
2019 Q1 | 150.62 Thousand PLN | 0.81% |
2019 FY | 509.3 Thousand PLN | 240.87% |
2019 Q4 | 509.3 Thousand PLN | 0.69% |
2018 Q1 | - PLN | -100.0% |
2018 Q2 | 191.77 Thousand PLN | 0.0% |
2018 Q3 | 192.89 Thousand PLN | 0.58% |
2018 FY | 149.41 Thousand PLN | 17.65% |
2018 Q4 | 149.41 Thousand PLN | -22.54% |
2017 FY | 126.99 Thousand PLN | -42.11% |
2017 Q4 | 126.99 Thousand PLN | 0.0% |
2016 FY | 219.39 Thousand PLN | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Adiuvo Investments S.A. | -1.12 Million PLN | 130.674% |
Genomtec S.A. | 1.11 Million PLN | 68.829% |
Medicalgorithmics S.A. | 2.46 Million PLN | 85.986% |
Synektik Spólka Akcyjna | 13.84 Million PLN | 97.502% |